Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...

M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.

Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration ...

The deal should allow Thermo to enter the filtration category in bioprocessing, where peers Danaher and Repligen are more ...

Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on ...

Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company's $4.1 billion deal to sell its filtration ...

Nvidia said sales, driven by the chips that power artificial intelligence, rose 78% to $39.3 billion in its latest quarter. Net income rose 80% to $22 billion. Both figures came in ahead of Wall ...

Good morning. English-Dutch food giant Unilever ousted its CEO Hein Schumacher this week, after barely one-and-a-half years ...

Read Our Latest Stock Report on SOLV Solventum Price Performance Shares of NYSE:SOLV opened at $73.08 on Monday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05 ...

Allworth Financial LP increased its stake in shares of Solventum Co. (NYSE:SOLV – Free Report) by 14.7% during the 4th quarter, according to its most recent disclosure with the SEC.The ...